Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I T Boyle

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
British Medical Journal|March 24, 1979
1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidismI T Boyle, I Fogelman, G H Beastall, et al.
British Medical Journal (Clinical Research Ed.)|June 14, 1986
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitoninS H Ralston, A A Alzaid, M D Gardner, et al.
Scottish Medical Journal|January 1, 1986
Preoperative localisation of parathyroid adenomasJ H McKillopp, I T Boyle, I G Gunn, et al.
The Journal of Biological Chemistry|June 25, 1973
The biological activity and metabolism of 24,25-dihydroxyvitamin D 3 I T Boyle, J L Omdahl, R W Gray, et al.
Scottish Medical Journal|October 1, 1993
Central nervous system histiocytosis X--imaging and responses to chemotherapyE Forrest, S J Gallacher, D Hadley, et al.
Community Dentistry and Oral Epidemiology|August 1, 1984
Five-year double-blind fluoridated milk study in ScotlandK W Stephen, I T Boyle, D Campbell, et al.
Lancet (London, England)|April 24, 1982
Diphosphonates and inhibition of bone mineralisationB F Boyce, L Smith, I Fogelman, et al.
British Journal of Rheumatology|December 1, 1991
Clinical profile of acute vertebral compression fractures in osteoporosisU Patel, S Skingle, G A Campbell, et al.
Calcified Tissue Research|May 1, 1977
1-alpha-Hydroxyvitamin D3 in the management of primary hyperparathyroidism with bone diseaseI T Boyle, I D Hodsman, B F Allam, et al.
Annals of Internal Medicine|April 1, 1990
Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patientsS H Ralston, S J Gallacher, U Patel, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
British Medical Journal|March 24, 1979
1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidismI T Boyle, I Fogelman, G H Beastall, et al.
British Medical Journal (Clinical Research Ed.)|June 14, 1986
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitoninS H Ralston, A A Alzaid, M D Gardner, et al.
Scottish Medical Journal|January 1, 1986
Preoperative localisation of parathyroid adenomasJ H McKillopp, I T Boyle, I G Gunn, et al.
The Journal of Biological Chemistry|June 25, 1973
The biological activity and metabolism of 24,25-dihydroxyvitamin D 3 I T Boyle, J L Omdahl, R W Gray, et al.
Scottish Medical Journal|October 1, 1993
Central nervous system histiocytosis X--imaging and responses to chemotherapyE Forrest, S J Gallacher, D Hadley, et al.
Community Dentistry and Oral Epidemiology|August 1, 1984
Five-year double-blind fluoridated milk study in ScotlandK W Stephen, I T Boyle, D Campbell, et al.
Lancet (London, England)|April 24, 1982
Diphosphonates and inhibition of bone mineralisationB F Boyce, L Smith, I Fogelman, et al.
British Journal of Rheumatology|December 1, 1991
Clinical profile of acute vertebral compression fractures in osteoporosisU Patel, S Skingle, G A Campbell, et al.
Calcified Tissue Research|May 1, 1977
1-alpha-Hydroxyvitamin D3 in the management of primary hyperparathyroidism with bone diseaseI T Boyle, I D Hodsman, B F Allam, et al.
Annals of Internal Medicine|April 1, 1990
Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patientsS H Ralston, S J Gallacher, U Patel, et al.
Pageof 12